Extremely proud of the @Brainomix teams working in partnership with @ActicorBiotech on the analysis of the ACTIMIS trial. We've been delighted to be able to unlock more insights into glenzocimab for patients with #stroke using our AI imaging biomarkers.
businesswire.com/news/home/2023…
businesswire.com/news/home/2023…